Skip to main content
. 2019 Oct 28;8(11):1806. doi: 10.3390/jcm8111806

Table 4.

Comparison of egg donation pregnancies according to serum creatinine and eGFR.

According to Creatinine (mg/dL) p-Values According to eGFR (mL/min) p-Values
sCr ≥ 0.67 sCr < 0.67 GFR < 90 GFR ≥ 90
n (%) 68 (54.8%) 56 (45.2%) 38 (30.6%) 86 (69.4%)
Age, median (min–max) 44 (32–55) 44 (31–56) 0.8363 45 (38–55) 44 (31–56) 0.1993
Parity, n. first (%) 64 (94.1%) 52 (92.9%) 0.7770 36 (94.7%) 80 (93.0%) 0.7214
BMI (kg·m−2), median (min–max) 22.0 (15.6–35.5) 22.8 (17.1–34.4) 0.8889 22.3 (15.6–34.0) 22.8 (17.1–35.5) 0.8816
No comorbidity, n (%) 31 (45.6%) 30 (53.6%) 0.3781 18 (47.4%) 60 (69.8%) 0.7878
Centiles at birth, median (min–max) 54 (0–98) 55 (1–100) 0.4483 40 (0–98) 58 (0–100) 0.1172
Pre-eclampsia, n (%) 24 (35.3%) 6 (10.7%) 0.0015 15 (39.5%) 15 (17.4%) 0.0085
Hypertension during pregnancy, n (%) * 43 (63.2%) 21 (37.5%) 0.0045 29 (76.3%) 35 (40.7%) 0.0003
Gestational hypertension, n (%) 31 (45.6%) 20 (35.7%) 0.2681 19 (50.0%) 32 (37.2%) 0.1838
Creatinine (mg·dL−1), median (min max) 0.75 (0.67–1.94) 0.57 (0.26–0.66) <0.0001 0.86 (0.69–1.94) 0.63 (0.26–0.86) <0.0001
GFR-EPI (mL·min−1), median (min-max) 87 (31–114) 114 (93–151) <0.0001 78 (31–89) 108 (90–151) <0.0001
Caesarean section, n (%) 53 (77.9%) 45 (80.4%) 0.7432 32 (84.2%) 66 (76.7%) 0.3484
Size for GA
Small, n (%)
Adeq, n (%)
Large, n (%)
 
9 (13.2%)
55 (80.9%)
4 (5.9%)
 
7 (12.5%)
42 (75.0%)
7 (12.5%)
0.4350  
6 (15.8%)
29 (76.3%)
3 (7.9%)
 
10 (11.6%)
68 (79.1%)
8 (9.3%)
0.8033 **
Pre-term
<37, n (%)
<34, n (%)
<32, n (%)
 
25 (36.8%)
9 (13.2%)
5 (7.4%)
 
8 (14.3%)
2 (3.6%)
1 (1.8%)
 
0.0050
0.0607
0.1522
 
16 (42.1%)
6 (15.8%)
4 (10.5%)
 
17 (19.8%)
5 (5.8%)
2 (2.3%)
 
0.0098
0.0728
0.0507

eGFR EPI: glomerular filtration rate calculated with the EPI formula; BMI: body mass index; GA: gestational age; PE: preeclampsia; Adeq. Adequate. HT Hypertension. * Hypertension in pregnancy: all cases regardless of previous hypertension. Gestational hypertension is hypertension during pregnancy in previously normotensive patients. ** Chi Square test for the difference in the distribution. Significant results in bold.